Accuray Incorporated

ARAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARAY stands at 141.1M. In comparison, DCTH has a market cap of 380M. Regarding current trading prices, ARAY is priced at $1.37, while DCTH trades at $10.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARAY currently has a P/E ratio of -34.25, whereas DCTH's P/E ratio is -24.24. In terms of profitability, ARAY's ROE is +0.01%, compared to DCTH's ROE of -0.35%. Regarding short-term risk, ARAY is less volatile compared to DCTH. This indicates potentially lower risk in terms of short-term price fluctuations for ARAY.Check DCTH's competition here

ARAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARAY stands at 141.1M. In comparison, COCHW has a market cap of 29.8M. Regarding current trading prices, ARAY is priced at $1.37, while COCHW trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARAY currently has a P/E ratio of -34.25, whereas COCHW's P/E ratio is N/A. In terms of profitability, ARAY's ROE is +0.01%, compared to COCHW's ROE of +1.06%. Regarding short-term risk, ARAY is less volatile compared to COCHW. This indicates potentially lower risk in terms of short-term price fluctuations for ARAY.Check COCHW's competition here